Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
Před 624 dny
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
Před 890 dny
Canadian Stocks Marginally Down In Cautious Trade
Canadian stocks are turning in a mixed performance on Tuesday with investors largely refraining from making significant moves amid lingering concerns about tariffs and some weak earnings updates.
RTTNews
|
Před 1 h 2 min
Swiss Market Ends Flat After Choppy Session
The Switzerland market closed slightly weak after a choppy ride on Tuesday as investors mostly stayed cautious, looking for fresh triggers. The Federal Reserve and the Bank of England are scheduled to announce their rate decisions on Wednesday and Thursday, respectively.
RTTNews
|
Před 1 h 32 min
European Stocks Close Broadly Lower Ahead Of Key Policy Announcements
European stocks closed broadly lower on Tuesday with investors largely staying cautious, following political and geopolitical developments, digesting economic and earnings updates, and awaiting the monetary policy announcements from the Federal Reserve and the Bank of England, due later in the week.
RTTNews
|
Před 1 h 48 min
UK Car Sales Drop 10.4% In April As Higher Taxes Hurt - SMMT
New car registrations in the U.K. decreased in April mainly due to customers making purchases early to avoid higher taxes that came into effect at the start of the month, though electric car sales continued to increase, monthly data from the Society of Motor Manufacturers and Traders showed on Tuesday.
RTTNews
|
Před 3 h 47 min
U.S. Trade Deficit Spikes To Record High In March As Import Surge
The U.S. trade deficit spiked by much more than expected in the month of March, according to a report released by the Commerce Department on Tuesday. The report said the trade deficit soared to a record high $140.5 billion in March from a revised $123.2 billion in February.
RTTNews
|
Před 4 h 33 min
Eurozone Private Sector Growth Eases On Weaker Demand
Euro area private sector growth weakened in April as soft demand conditions limited the speed of expansion and weighed on sentiment, final results of the purchasing managers' survey by S&P Global showed on Tuesday. The HCOB final composite output index fell to 50.4 in April from 50.9 in March, but the reading suggested growth for the fourth straight month.
RTTNews
|
Před 5 h 36 min
